Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Non-Current Assets: 2024-2025

Historic Non-Current Assets for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $22.5 million.

  • Pyxis Oncology's Non-Current Assets fell 51.49% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year decrease of 51.49%. This contributed to the annual value of $24.7 million for FY2024, which is N/A change from last year.
  • Per Pyxis Oncology's latest filing, its Non-Current Assets stood at $22.5 million for Q3 2025, which was down 3.13% from $23.3 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Non-Current Assets registered a high of $47.8 million during Q1 2024, and its lowest value of $22.5 million during Q3 2025.
  • Its 2-year average for Non-Current Assets is $33.7 million, with a median of $24.7 million in 2024.
  • Data for Pyxis Oncology's Non-Current Assets shows a maximum YoY plummeted of 51.49% (in 2025) over the last 5 years.
  • Pyxis Oncology's Non-Current Assets (Quarterly) stood at $24.7 million in 2024, then tumbled by 51.49% to $22.5 million in 2025.
  • Its Non-Current Assets stands at $22.5 million for Q3 2025, versus $23.3 million for Q2 2025 and $24.0 million for Q1 2025.